Nom du produit:4-cyclobutyl-2-methyl-5-(5-methyl-4H-1,2,4-triazol-3-yl)benzoicacid
IUPAC Name:4-cyclobutyl-2-methyl-5-(3-methyl-1H-1,2,4-triazol-5-yl)benzoic acid
- CAS：1399181-93-1
- Formule moléculaire：C15H17N3O2
- Pureté：95%+
- Numéro de catalogue：CM1075241
- Poids moléculaire：271.32
| Unité d'emballage |
Stock disponible |
Prix($) |
Quantité |
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:1399181-93-1
- Formule moléculaire:C15H17N3O2
- Point de fusion:-
- Code SMILES:CC1=NNC(=N1)C1=C(C=C(C)C(=C1)C(O)=O)C1CCC1
- Densité:
- Numéro de catalogue:CM1075241
- Poids moléculaire:271.32
- Point d'ébullition:
- N° Mdl:
- Stockage:
Category Infos
- Triazoles
- Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.
Column Infos
- Denifanstat
- Sagimet Biosciences announced positive topline results from its FASCINATE-2 Phase 2b clinical trial of denifanstat versus placebo in biopsy-confirmed non-alcoholic steatohepatitis (NASH) patients with stage 2 or stage 3 fibrosis (F2/F3) at week 52. Denifanstat, an oral, selective FASN inhibitor, achieved statistically significant results on primary and multiple secondary endpoints.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.
Recherche 
+86 21 5895 0110 
